Growth of a nation part I: Impact of organ donor obesity on whole-organ pancreas transplantation

Jonathan A. Fridell, Richard Mangus, Tim Taber, Michelle L. Goble, Martin L. Milgrom, Jason Good, Ryan Vetor, John A. Powelson

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Obesity has reached epidemic proportions in the USA. Consequently, there are an increasing number of potential organ donors that are obese, but would otherwise be appropriate donors for pancreas transplantation (PTx). This is a retrospective study of all PTx performed at Indiana University between 2003 and 2009 (n=308) comparing donors with body mass index (BMI) <25, 25-29.9, and ≥30kg/m2. Data included recipient and donor demographics, seven and 90-d graft loss, one-yr pancreas, kidney (for simultaneous pancreas and kidney transplant only) and patient survival, causes of graft loss and death, peak amylase and lipase, length of stay, readmissions, complications, HbA1C, and c-peptide. Of the 308 donors, 84 (27%) were overweight and 43 (14%) were obese. The overweight donors were significantly older, and the obese donors had hypertension significantly more frequently than the other two groups. There were no significant differences in recipient transplant demographics. There was no significant difference in length of stay or 90-d readmissions, seven or 90-d pancreas graft loss, one-yr graft or patient survival, peak serum amylase or lipase, HbA1C, or c-peptide. The incidence of post-transplant technical, immunological, and infectious complications were similar. Although technically challenging, PTx of allografts from obese donors can be accomplished with similar results compared to normal BMI donors.

Original languageEnglish
JournalClinical Transplantation
Volume25
Issue number3
DOIs
StatePublished - May 2011

Fingerprint

Pancreas Transplantation
Organ Transplantation
Obesity
Tissue Donors
Growth
Transplants
Pancreas
Amylases
Lipase
Length of Stay
Body Mass Index
Demography
Kidney
Peptides
Graft Survival
Allografts
Retrospective Studies
Hypertension
Survival

Keywords

  • Obesity
  • Organ donor
  • Pancreas transplantation

ASJC Scopus subject areas

  • Transplantation

Cite this

Growth of a nation part I : Impact of organ donor obesity on whole-organ pancreas transplantation. / Fridell, Jonathan A.; Mangus, Richard; Taber, Tim; Goble, Michelle L.; Milgrom, Martin L.; Good, Jason; Vetor, Ryan; Powelson, John A.

In: Clinical Transplantation, Vol. 25, No. 3, 05.2011.

Research output: Contribution to journalArticle

Fridell, Jonathan A. ; Mangus, Richard ; Taber, Tim ; Goble, Michelle L. ; Milgrom, Martin L. ; Good, Jason ; Vetor, Ryan ; Powelson, John A. / Growth of a nation part I : Impact of organ donor obesity on whole-organ pancreas transplantation. In: Clinical Transplantation. 2011 ; Vol. 25, No. 3.
@article{215c50901fc342809b5679d362147474,
title = "Growth of a nation part I: Impact of organ donor obesity on whole-organ pancreas transplantation",
abstract = "Obesity has reached epidemic proportions in the USA. Consequently, there are an increasing number of potential organ donors that are obese, but would otherwise be appropriate donors for pancreas transplantation (PTx). This is a retrospective study of all PTx performed at Indiana University between 2003 and 2009 (n=308) comparing donors with body mass index (BMI) <25, 25-29.9, and ≥30kg/m2. Data included recipient and donor demographics, seven and 90-d graft loss, one-yr pancreas, kidney (for simultaneous pancreas and kidney transplant only) and patient survival, causes of graft loss and death, peak amylase and lipase, length of stay, readmissions, complications, HbA1C, and c-peptide. Of the 308 donors, 84 (27{\%}) were overweight and 43 (14{\%}) were obese. The overweight donors were significantly older, and the obese donors had hypertension significantly more frequently than the other two groups. There were no significant differences in recipient transplant demographics. There was no significant difference in length of stay or 90-d readmissions, seven or 90-d pancreas graft loss, one-yr graft or patient survival, peak serum amylase or lipase, HbA1C, or c-peptide. The incidence of post-transplant technical, immunological, and infectious complications were similar. Although technically challenging, PTx of allografts from obese donors can be accomplished with similar results compared to normal BMI donors.",
keywords = "Obesity, Organ donor, Pancreas transplantation",
author = "Fridell, {Jonathan A.} and Richard Mangus and Tim Taber and Goble, {Michelle L.} and Milgrom, {Martin L.} and Jason Good and Ryan Vetor and Powelson, {John A.}",
year = "2011",
month = "5",
doi = "10.1111/j.1399-0012.2011.01419.x",
language = "English",
volume = "25",
journal = "Clinical Transplantation",
issn = "0902-0063",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Growth of a nation part I

T2 - Impact of organ donor obesity on whole-organ pancreas transplantation

AU - Fridell, Jonathan A.

AU - Mangus, Richard

AU - Taber, Tim

AU - Goble, Michelle L.

AU - Milgrom, Martin L.

AU - Good, Jason

AU - Vetor, Ryan

AU - Powelson, John A.

PY - 2011/5

Y1 - 2011/5

N2 - Obesity has reached epidemic proportions in the USA. Consequently, there are an increasing number of potential organ donors that are obese, but would otherwise be appropriate donors for pancreas transplantation (PTx). This is a retrospective study of all PTx performed at Indiana University between 2003 and 2009 (n=308) comparing donors with body mass index (BMI) <25, 25-29.9, and ≥30kg/m2. Data included recipient and donor demographics, seven and 90-d graft loss, one-yr pancreas, kidney (for simultaneous pancreas and kidney transplant only) and patient survival, causes of graft loss and death, peak amylase and lipase, length of stay, readmissions, complications, HbA1C, and c-peptide. Of the 308 donors, 84 (27%) were overweight and 43 (14%) were obese. The overweight donors were significantly older, and the obese donors had hypertension significantly more frequently than the other two groups. There were no significant differences in recipient transplant demographics. There was no significant difference in length of stay or 90-d readmissions, seven or 90-d pancreas graft loss, one-yr graft or patient survival, peak serum amylase or lipase, HbA1C, or c-peptide. The incidence of post-transplant technical, immunological, and infectious complications were similar. Although technically challenging, PTx of allografts from obese donors can be accomplished with similar results compared to normal BMI donors.

AB - Obesity has reached epidemic proportions in the USA. Consequently, there are an increasing number of potential organ donors that are obese, but would otherwise be appropriate donors for pancreas transplantation (PTx). This is a retrospective study of all PTx performed at Indiana University between 2003 and 2009 (n=308) comparing donors with body mass index (BMI) <25, 25-29.9, and ≥30kg/m2. Data included recipient and donor demographics, seven and 90-d graft loss, one-yr pancreas, kidney (for simultaneous pancreas and kidney transplant only) and patient survival, causes of graft loss and death, peak amylase and lipase, length of stay, readmissions, complications, HbA1C, and c-peptide. Of the 308 donors, 84 (27%) were overweight and 43 (14%) were obese. The overweight donors were significantly older, and the obese donors had hypertension significantly more frequently than the other two groups. There were no significant differences in recipient transplant demographics. There was no significant difference in length of stay or 90-d readmissions, seven or 90-d pancreas graft loss, one-yr graft or patient survival, peak serum amylase or lipase, HbA1C, or c-peptide. The incidence of post-transplant technical, immunological, and infectious complications were similar. Although technically challenging, PTx of allografts from obese donors can be accomplished with similar results compared to normal BMI donors.

KW - Obesity

KW - Organ donor

KW - Pancreas transplantation

UR - http://www.scopus.com/inward/record.url?scp=79958760237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958760237&partnerID=8YFLogxK

U2 - 10.1111/j.1399-0012.2011.01419.x

DO - 10.1111/j.1399-0012.2011.01419.x

M3 - Article

C2 - 21362050

AN - SCOPUS:79958760237

VL - 25

JO - Clinical Transplantation

JF - Clinical Transplantation

SN - 0902-0063

IS - 3

ER -